Articles from Biotech Financial Reports (October 1, 1999)

Title	Author	Type	Words
ANIKA EXPECTS REVENUE AND EARNINGS SHORTFALL FOR THIRD QUARTER.			411
CANDELA SHATTERS REVENUE/PROFIT RECORDS IN FINAL QTR OF 1999.			465
CAPRIUS REPORTS THIRD QUARTER NET LOSS.			223
DERMA SCIENCES REPORTS INCREASE IN NET SALES FOR 2ND QUARTER.			298
ENZON REPORTS NET LOSS FOR FISCAL YEAR.			580
NEXMED REPORTS NET LOSS FOR SECOND QUARTER.			297
PALL REPORTS 27 PERCENT INCREASE IN FOURTH QUARTER EARNINGS.			859
ZYMETX REPORTS NET LOSS FOR FOURTH QUARTER.			671